Microbot Medical Inc.
MBOT
$2.23
-$0.26-10.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.55% | -31.44% | -7.78% | 16.89% | -5.20% |
| Total Depreciation and Amortization | -25.71% | 15.00% | -46.15% | 12.00% | 6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.47% | 5.64% | -2.93% | 17.66% | 480.38% |
| Change in Net Operating Assets | 220.31% | -69.90% | 146.97% | 30.26% | -1,564.56% |
| Cash from Operations | 7.14% | -66.71% | -5.56% | 24.45% | 26.07% |
| Capital Expenditure | -240.00% | 100.00% | 60.00% | -- | 600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.15% | 105.50% | 192.61% | -144.05% | 178.73% |
| Cash from Investing | -49.44% | 105.44% | 191.58% | -144.54% | 178.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -69.13% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 493.17% | -69.13% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.04% | 54.74% | -63.50% | -308.44% | 160.04% |